文献速递关节外科

术前镍过敏患者全膝关节置换术使用钴铬或免镍假体的临床结局比较

A Comparison of Clinical Outcomes After Total Knee Arthroplasty in Patients With Preoperative Nickel Allergy Receiving Cobalt Chromium or Nickel-Free Implant.
PubMed 文献 · J Arthroplasty · 2023-04-25

回顾性分析2016至2020年间20,324例单侧初次全膝关节置换术,其中282例存在术前镍过敏,243例使用免镍假体、39例使用钴铬假体。两组翻修率无显著差异(免镍组无翻修生存率98% vs 钴铬组94%,P=0.9),术前、术后6周及1年的临床 outcome 评分亦无差异。结论认为镍过敏患者使用钴铬或免镍假体的翻修率与临床结局无差异,需进一步研究明确镍过敏是否为TKA结局较差的独立危险因素。

要点

  • 术前镍过敏患者中,免镍假体组与钴铬假体组的翻修率无显著差异(P=0.9)。
  • 两组术前、术后6周及1年的KOOS-JR、VAS、LEAS、PROMIS及VR-12评分均无差异。
  • 免镍假体组无翻修生存率为98%,钴铬假体组为94%。

核心结论

  • 在回顾性队列研究中,术前镍过敏患者行初次全膝关节置换术使用钴铬或免镍假体的翻修率与临床结局无差异。
  • 需进一步研究以确定镍过敏是否为TKA结局较差的独立危险因素。

研究设计与样本

  • 回顾性综述,纳入2016年至2020年间17,798例患者共20,324例单侧初次全膝关节置换术。
  • 确定术前镍过敏患者282例,分为免镍假体组(n=243)和钴铬假体组(n=39),评估临床结局评分与翻修率。

主要发现

  • 免镍假体组无翻修生存率为98%,钴铬假体组为94%(P=0.9),两组翻修率无显著差异。
  • 两组术前、术后6周及1年的KOOS-JR、VAS、LEAS、PROMIS及VR-12评分均无差异。

关键数值与推荐

  • 免镍假体组无翻修生存率98% vs 钴铬假体组94%(P=0.9)。
  • 两组翻修率无显著差异。
  • 两组术前、6周、1年KOOS-JR、VAS、LEAS、PROMIS、VR-12评分均无差异。

临床怎么用

  • 原文结论未据此给出推荐。

局限性

  • 需进一步研究以确定镍过敏是否为TKA结局较差的独立危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The role of metal hypersensitivity reactions in total knee arthroplasty (TKA) failure is debated. There is no consensus on whether use of a more expensive nickel-free implant is indicated for patients who have preoperative nickel allergy. The purpose of this study was to examine the outcome of patients who have preoperative nickel allergy receiving nickel-free or cobalt chromium (CoCr) implants. METHODS: This was a retrospective review of 17,798 patients who underwent 20,324 unilateral primary TKAs between 2016 and 2020. Presence of preoperative nickel allergy was determined (n = 282). Patients were divided into 2 cohorts: those receiving (1) nickel-free or (2) CoCr implants. Clinical outcome scores and revision rates were assessed. RESULTS: 243 received a nickel-free implant and 39 received a CoCr implant. There was no significant difference in revision rate between the cohorts. Survivorship free of revision was 94% in the CoCr implant cohort and 98% in the nickel-free implant cohort (P = .9). When comparing clinical outcome scores between cohorts, there was no difference in preoperative, 6-week or 1-year Knee Osteoarthritis Outcome Score Joint Replacement, Visual Analog Scale (VAS), Lower Extremity Activity Scale, Patient-Reported Outcomes Measurement Information System (PROMIS), and Veterans RAND 12-item scores between cohorts. CONCLUSION: In this retrospective cohort study, there was no difference in revision rates or clinical outcomes in patients who had a nickel allergy undergoing primary TKA with CoCr or nickel-free implants. Further studies are needed to determine if nickel allergy is an independent risk factor for worse TKA outcomes in general.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Siljander BR, Chandi SK, Debbi EM, et al. A Comparison of Clinical Outcomes After Total Knee Arthroplasty in Patients With Preoperative Nickel Allergy Receiving Cobalt Chromium or Nickel-Free Implant. J Arthroplasty. 2023. PMID: 37100098. doi:10.1016/j.arth.2023.04.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。